Interphase detection of trisomy 12 in B-cell chronic lymphocytic leukemia by fluorescence hybridization in situ

M B Qumsiyeh1, S A Tharapel

  • 1Cytogenetics Laboratory, University of Tennessee, Chattanooga 37403.

Leukemia
|June 1, 1992
PubMed

Insights

Fluorescence in situ hybridization detected trisomy 12 in four of seven B-cell chronic lymphocytic leukemia cases. This method aids in understanding chromosome abnormalities in B-CLL.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoproliferative disorder.
  • Chromosome abnormalities play a role in B-CLL pathogenesis and prognosis.
  • Classic cytogenetic methods can be limited in detecting certain abnormalities.

Purpose of the Study:

  • To investigate the utility of fluorescence in situ hybridization (FISH) for detecting trisomy 12 in B-CLL.
  • To evaluate the frequency of trisomy 12 in a cohort of B-CLL patients.
  • To assess FISH as a complementary diagnostic tool for B-CLL.

Main Methods:

  • FISH was performed using a probe specific for the alphoid sequence of the centromeric region of chromosome 12.
  • Seven cases of B-CLL were analyzed.
  • Interphase nuclei and metaphase spreads were examined for the presence of trisomy 12.

Main Results:

  • Trisomy 12 was detected in interphase cells of one case lacking analyzable metaphases.
  • Four out of seven B-CLL cases exhibited clear evidence of trisomy 12 in interphase nuclei.
  • FISH successfully identified trisomy 12 in cases where conventional cytogenetics was insufficient.

Conclusions:

  • FISH is a valuable tool for detecting trisomy 12 in B-CLL, even in cases with poor metaphase quality.
  • The findings suggest trisomy 12 is a recurrent abnormality in B-CLL.
  • FISH enhances cytogenetic analysis in B-CLL, potentially improving clinical correlation of chromosomal aberrations.